p21-Activated kinase 4 predicts early recurrence and poor survival in patients with nonmetastatic clear cell renal cell carcinoma

Urologic Oncology
Weisi LiuJiejie Xu

Abstract

p21-Activated kinase 4 (PAK4), a serine/threonine kinase implicated in the cytoskeleton organization to orchestrate cell morphology, adhesion, and motility, is associated with angiogenesis and vessel branching, which are important events in the progression of clear cell renal cell carcinoma (ccRCC). We investigated the effect of PAK4 expression on recurrence and survival among patients with nonmetastatic ccRCC following surgery. PAK4 expression was assessed, using immunohistochemistry, in 376 patients with nonmetastatic ccRCC after nephrectomy, where data of 187 patients were obtained from 2013 to 2014 and of 189 patients were obtained from 2008. Kaplan-Meier and Cox regression analyses were used to associate PAK4 expression with overall survival and recurrence-free survival. Overall, 41.2% and 36.5% of specimens exhibited high PAK4 expression in 2 cohorts. Patients with high PAK4 expression were prone to possess high Fuhrman grade and tumor necrosis. Moreover, high PAK4 intensity was significantly associated with poor overall survival and recurrence-free survival. PAK4 expression remained an independent adverse prognosticator after adjusting for other well-established factors. Furthermore, in subgroups stratified by Fuhrman gr...Continue Reading

References

May 3, 2003·Cancer Cell·Nicola J MabjeeshParaskevi Giannakakou
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael B AtkinsLaura King
Mar 30, 2007·The Journal of Biological Chemistry·Ulrike E E RennefahrtJeffrey R Peterson
Jul 11, 2007·International Journal of Cancer. Journal International Du Cancer·Gerald C O'SullivanOrla P Barry
Jan 18, 2008·Biology of the Cell·Luis E Arias-Romero, Jonathan Chernoff
Apr 13, 2010·The Lancet Oncology·Kyle A FurgeBin T Teh
Oct 12, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michelle K Y SiuAnnie N Y Cheung
Apr 14, 2011·Nature Reviews. Urology·Grant D StewartDana Faratian
Jun 2, 2012·EMBO Reports·Yohendran BaskaranEd Manser
Nov 20, 2012·Cellular Logistics·Diana Zi Ye, Jeffrey Field
Mar 15, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayF Bray
May 7, 2013·European Journal of Cell Biology·Anna E Dart, Claire M Wells
Jul 10, 2013·Nature Reviews. Clinical Oncology·Annette Fenner
Oct 17, 2013·Carcinogenesis·Tae Woo KimKyung Chan Park
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Feb 8, 2014·Nature Reviews. Cancer·Maria RaduJonathan Chernoff

❮ Previous
Next ❯

Citations

Dec 17, 2015·Urologic Oncology·Bryan J ThibodeauJason Hafron
May 31, 2017·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Sehhoon ParkHo-Seong Han
Jul 6, 2017·Oncology Reports·Xianghe LuWenfeng Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.